Marken adds three cities to LATAM offering, others in test phase

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/frankpeters)
(Image: Getty/frankpeters)
Marken has expanded its hybrid clinical logistics service in Latin American – from which an estimated 2,000 daily shipments to the US originate.

The hybrid service, which uses UPS’ network for a portion of shipment routes​, was launched in May 2017.

Marken​ yesterday announced that it will offer similar services from Guadalajara (GDL), Monterey (MTY), and Buenos Aires (EZE) airports to the US. 

Additional cities in Latin American (LATAM) are currently in a test phase and are expected to be available in the future, according to the company.

Adding Guadalajara, Monterey and Buenos Aires to our hybrid service offering is a major advance in our LATAM clinical portfolio,"​ said Wes Wheeler, Marken CEO.

"We are the first to load biological sample shipments onto an integrator flight from Buenos Aires (EZE) using the UPS airline, which then allows us to arrive at any US laboratory early the next morning."

According to the clinical trial logistics provider, there are an estimated 2,000 daily shipments from LATAM into laboratories in the US – of which nearly 50% originate in Mexico and Argentina.  

Related news

Show more

Related products

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us

Products

View more

Webinars